Are Roweepra and Briviact the Same Thing?
Roweepra (levetiracetam) and Briviact (brivaracetam) are antiseizure (antiepileptic) drugs indicated for adjunctive therapy in the treatment of partial onset seizures with epilepsy.
Roweepra is also used to treat myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy.
Side effects of Roweepra and Briviact that are similar include drowsiness, dizziness, fatigue, and irritability.
Side effects of Roweepra that are different from Briviact include weakness, infection, aggression, stuffy nose, and decreased appetite.
Side effects of Briviact that are different from Roweepra include sedation, nausea, vomiting, loss of balance or coordination, and constipation.
Roweepra may interact with other drugs.
Briviact may interact with rifampin, carbamazepine, and phenytoin.
Antiepileptic drugs, including Roweepra and Briviact, should be withdrawn gradually to minimize the potential of increased seizure frequency.
What Are Possible Side Effects of Roweepra?
Common side effects of Roweepra include:
- drowsiness,
- weakness,
- infection, and
- dizziness.
Common side effects of Roweepra in children include:
- fatigue,
- aggression,
- stuffy nose,
- decreased appetite, and
- irritability.
Antiepileptic drugs (AEDs), including Roweepra, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication. Tell your doctor if this occurs.
What Are Possible Side Effects of Briviact?
Common side effects of Briviact include:
- drowsiness,
- sedation,
- dizziness,
- fatigue,
- nausea,
- vomiting,
- loss of balance or coordination,
- irritability, and
- constipation
Antiepileptic drugs, including Briviact, may increase the risk of suicidal thoughts or behavior in patients taking these drugs. Tell your doctor immediately if this occurs.
What Is Roweepra?
Roweepra (levetiracetam) is an antiseizure (antiepileptic) drug indicated for adjunctive therapy in the treatment of partial onset seizures in patients one month of age and older with epilepsy, myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy. Roweepra is available in generic form.
What Is Briviact?
Briviact (brivaracetam) is an antiepileptic drug (AED) indicated as adjunctive therapy in the treatment of partial-onset seizures in patients 16 years of age and older with epilepsy.
How Should Roweepra Be Taken?
The Roweepra dosing regimen depends on the indication, age group, dosage form (tablets or oral solution), and renal function.
How Should Briviact Be Taken?
The recommended starting dosage of Briviact is 50 mg twice daily. Based on individual patient tolerability and therapeutic response, the dosage of Briviact may be adjusted down to 25 mg twice daily (50 mg per day) or up to 100 mg twice daily (200 mg per day).
From 
Brain & Nervous Resources
Featured Centers
Health Solutions From Our Sponsors
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eb66dee6-1d92-4b2d-ae4a-232faf129f24
UCB. Briviact Product Information.
https://www.briviact.com